3.60
-0.08 (-2.17%)
-0.08 (-2.17%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 721,923 |
|
|||||
| News | - | ||||||
| Day High | 3.6999 | Low High |
|||||
| Day Low | 3.505 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.08 | -2.17% | 3.60 | 17:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.60 | 3.505 | 3.6999 | 3.60 | 3.68 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,113 | 721,923 | $ 3.56 | $ 2,568,021 | - | 3.15 - 9.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:56:49 | 5 | $ 3.66 | USD |
Period:
Draw Mode:
Zynerba Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 148.38M | 41.22M | 39.95M | $ - | $ - | -1.93 | -3.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 75.00k | 6.00% |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.81 | 3.86 | 3.48 | 3.65 | 1,862,667 | -0.21 | -5.51% |
| 1 Month | 3.81 | 4.355 | 3.48 | 3.95 | 1,871,132 | -0.21 | -5.51% |
| 3 Months | 4.53 | 4.6499 | 3.48 | 4.09 | 1,569,506 | -0.93 | -20.53% |
| 6 Months | 4.93 | 6.07 | 3.48 | 4.43 | 1,636,814 | -1.33 | -26.98% |
| 1 Year | 4.5326 | 9.00 | 3.15 | 4.87 | 2,490,291 | -0.9326 | -20.58% |
| 3 Years | 5.26 | 16.47 | 2.55 | 6.16 | 1,557,154 | -1.66 | -31.56% |
| 5 Years | 14.10 | 25.95 | 2.55 | 7.14 | 1,135,669 | -10.50 | -74.47% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. |
